Join
Live feed
·
PRReleasevia Quantisnow
Better Therapeutics Inc. logo

Better Therapeutics Announces Positive Primary Endpoint Data From Pivotal Clinical Trial of BT-001, a Prescription Digital Therapeutic (PDT) for Patients With Uncontrolled Type 2 Diabetes

ByQuantisnow·Wall Street's wire, on your screen.
BTTX· Better Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BTTX (Better Therapeutics Inc.) and more on Quantisnow.